24 Hrs
Source:
Financial Times
Moderna's breakthrough stirs pandemic memories
Biotech stocks surged nearly threefold after a biotech company's mRNA cancer treatment demonstrated promising results. The company, which had faced difficulties in recent years, experienced renewed investor confidence due to the positive developments. The breakthrough suggests potential for the company's cancer therapy in upcoming clinical applications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)